申请人:Merck Sharp & Dohme Corp.
                            
                            
                                公开号:US20150329539A1
                            
                            
                                公开(公告)日:2015-11-19
                            
                            The present invention relates to 4-Pyridinonetriazine Derivatives of Formula (I); and pharmaceutically acceptable salts thereof, wherein A, X, Y, R
1
, R
2
, R
3
and R
5
are as defined herein. The present invention also relates to compositions comprising at least one 4-Pyridinonetriazine Derivative, and methods of using the 4-Pyridinonetriazine Derivatives for treating or preventing HIV infection in a subject.